Literature DB >> 18430557

The role of fatty acids in the development and progression of nonalcoholic fatty liver disease.

Christopher L Gentile1, Michael J Pagliassotti.   

Abstract

Nonalcoholic fatty liver disease (NAFLD) has emerged as a serious obesity-related disorder. NAFLD encompasses a wide spectrum of hepatic derangements ranging from a surfeit of fat in the liver (steatosis) to lipid surplus accompanied by fibrosis and cellular death (nonalcoholic steatohepatitis or NASH). The most widely accepted model to explain the progression from simple NAFLD to NASH is the "two-hit hypothesis," wherein fat over accumulation per se is not sufficient to induce the progression to statohepatitis, but renders the liver more susceptible to "second hits" that, once imposed upon the steatotic liver, cause further aberrations that culminate in the development of NASH. However, in light of recent data from our laboratory and elsewhere, we propose that an increased ratio of saturated-to-unsaturated fatty acids delivered to or stored within the liver may, in part, mediate the progression from simple steatosis to NASH. The molecular mechanisms that mediate the effect of saturated fatty acids are unclear, although proinflammatory cytokines, reactive oxygen species, and endoplasmic reticulum stress may all play a role. Collectively, these data suggest that saturated fatty acids may represent an intrinsic second hit to the liver that hastens the development of NASH.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18430557      PMCID: PMC2551556          DOI: 10.1016/j.jnutbio.2007.10.001

Source DB:  PubMed          Journal:  J Nutr Biochem        ISSN: 0955-2863            Impact factor:   6.048


  108 in total

Review 1.  Nonalcoholic fatty liver disease.

Authors:  Pouneh S Mofrad; Arun J Sanyal
Journal:  MedGenMed       Date:  2003-04-16

2.  Underglycosylation of ATF6 as a novel sensing mechanism for activation of the unfolded protein response.

Authors:  Min Hong; Shengzhan Luo; Peter Baumeister; Jen-Ming Huang; Raveen K Gogia; Mingqing Li; Amy S Lee
Journal:  J Biol Chem       Date:  2003-12-29       Impact factor: 5.157

Review 3.  Endoplasmic reticulum stress in health and disease.

Authors:  Lihong Zhao; Susan L Ackerman
Journal:  Curr Opin Cell Biol       Date:  2006-06-16       Impact factor: 8.382

4.  High-fat emulsion-induced rat model of nonalcoholic steatohepatitis.

Authors:  Yuhong Zou; Jun Li; Chao Lu; Jianqing Wang; Jinfang Ge; Yan Huang; Lei Zhang; Yuanyuan Wang
Journal:  Life Sci       Date:  2006-03-24       Impact factor: 5.037

5.  Nonalcoholic fatty liver disease and risk of future cardiovascular events among type 2 diabetic patients.

Authors:  Giovanni Targher; Lorenzo Bertolini; Felice Poli; Stefano Rodella; Luca Scala; Roberto Tessari; Luciano Zenari; Giancarlo Falezza
Journal:  Diabetes       Date:  2005-12       Impact factor: 9.461

6.  Triglyceride accumulation protects against fatty acid-induced lipotoxicity.

Authors:  Laura L Listenberger; Xianlin Han; Sarah E Lewis; Sylvaine Cases; Robert V Farese; Daniel S Ory; Jean E Schaffer
Journal:  Proc Natl Acad Sci U S A       Date:  2003-03-10       Impact factor: 11.205

7.  Palmitate induced mitochondrial deoxyribonucleic acid damage and apoptosis in l6 rat skeletal muscle cells.

Authors:  L I Rachek; S I Musiyenko; S P LeDoux; G L Wilson
Journal:  Endocrinology       Date:  2006-10-05       Impact factor: 4.736

8.  Metabolic syndrome is associated with greater histologic severity, higher carbohydrate, and lower fat diet in patients with NAFLD.

Authors:  Hellan Kang; Joel K Greenson; Jason T Omo; Cewin Chao; Debra Peterman; Lilian Anderson; Laura Foess-Wood; Mary A Sherbondy; Hari S Conjeevaram
Journal:  Am J Gastroenterol       Date:  2006-10       Impact factor: 10.864

9.  Leptin deficiency enhances sensitivity to endotoxin-induced lethality.

Authors:  R Faggioni; G Fantuzzi; C Gabay; A Moser; C A Dinarello; K R Feingold; C Grunfeld
Journal:  Am J Physiol       Date:  1999-01

10.  Beef fat prevents alcoholic liver disease in the rat.

Authors:  A A Nanji; C L Mendenhall; S W French
Journal:  Alcohol Clin Exp Res       Date:  1989-02       Impact factor: 3.455

View more
  79 in total

1.  Inhibitory effect of schisandrin B on free fatty acid-induced steatosis in L-02 cells.

Authors:  Jian-Hong Chu; Hui Wang; Yan Ye; Ping-Kei Chan; Si-Yuan Pan; Wang-Fun Fong; Zhi-Ling Yu
Journal:  World J Gastroenterol       Date:  2011-05-21       Impact factor: 5.742

2.  Plasma free myristic acid proportion is a predictor of nonalcoholic steatohepatitis.

Authors:  Kengo Tomita; Toshiaki Teratani; Hirokazu Yokoyama; Takahiro Suzuki; Rie Irie; Hirotoshi Ebinuma; Hidetsugu Saito; Ryota Hokari; Soichiro Miura; Toshifumi Hibi
Journal:  Dig Dis Sci       Date:  2011-04-23       Impact factor: 3.199

3.  Role of ceramides in nonalcoholic fatty liver disease.

Authors:  Mangesh Pagadala; Takhar Kasumov; Arthur J McCullough; Nizar N Zein; John P Kirwan
Journal:  Trends Endocrinol Metab       Date:  2012-05-17       Impact factor: 12.015

Review 4.  Hepatocyte death: a clear and present danger.

Authors:  Harmeet Malhi; Maria Eugenia Guicciardi; Gregory J Gores
Journal:  Physiol Rev       Date:  2010-07       Impact factor: 37.312

5.  Role of unfolded protein response in lipogenesis.

Authors:  Ze Zheng; Chunbin Zhang; Kezhong Zhang
Journal:  World J Hepatol       Date:  2010-06-27

6.  Experimental evidence for therapeutic potential of taurine in the treatment of nonalcoholic fatty liver disease.

Authors:  Christopher L Gentile; Angela M Nivala; Jon C Gonzales; Kyle T Pfaffenbach; Dong Wang; Yuren Wei; Hua Jiang; David J Orlicky; Dennis R Petersen; Michael J Pagliassotti; Kenneth N Maclean
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2011-09-28       Impact factor: 3.619

7.  Label-free imaging and analysis of the effects of lipolysis products on primary hepatocytes.

Authors:  Iwan W Schie; Jian Wu; Tyler Weeks; Mark A Zern; John C Rutledge; Thomas Huser
Journal:  J Biophotonics       Date:  2010-09-28       Impact factor: 3.207

8.  Predictors of all-cause mortality and liver-related mortality in patients with non-alcoholic fatty liver disease (NAFLD).

Authors:  Maria Stepanova; Nila Rafiq; Hala Makhlouf; Ritambhara Agrawal; Ishmeet Kaur; Zahra Younoszai; Arthur McCullough; Zachary Goodman; Zobair M Younossi
Journal:  Dig Dis Sci       Date:  2013-06-18       Impact factor: 3.199

9.  The effects of α-lipoic acid on liver oxidative stress and free fatty acid composition in methionine-choline deficient diet-induced NAFLD.

Authors:  Milena N Stanković; Dušan Mladenović; Milica Ninković; Ivana Ethuričić; Slađana Sobajić; Bojan Jorgačević; Silvio de Luka; Rada Jesic Vukicevic; Tatjana S Radosavljević
Journal:  J Med Food       Date:  2013-12-10       Impact factor: 2.786

10.  Role of dietary fatty acids in liver injury caused by vinyl chloride metabolites in mice.

Authors:  Lisanne C Anders; Heegook Yeo; Brenna R Kaelin; Anna L Lang; Adrienne M Bushau; Amanda N Douglas; Matt Cave; Gavin E Arteel; Craig J McClain; Juliane I Beier
Journal:  Toxicol Appl Pharmacol       Date:  2016-09-28       Impact factor: 4.219

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.